AAAAAA
Results:
1-23
|
Results: 23
Authors:
LARRAMENDY ML
HUHTA T
VETTENRANTA K
ELRIFAI W
LUNDIN J
PAKKALA S
SAARINENPIHKALA UM
KNUUTILA S
Citation: Ml. Larramendy et al., COMPARATIVE GENOMIC HYBRIDIZATION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia, 12(10), 1998, pp. 1638-1644
Authors:
PAKKALA I
SAVLI H
KNUUTILA S
BINDERUP L
PAKKALA S
Citation: I. Pakkala et al., CB1093, A NOVEL VITAMIN-D ANALOG - EFFECTS ON DIFFERENTIATION AND CLONAL GROWTH ON HL-60 AND DE-NOVO LEUKEMIA-CELLS, Leukemia research, 21(4), 1997, pp. 321-326
Authors:
PAKKALA I
RAISANENSOKOLOWSKI A
TASKINEN E
PAKKALA S
Citation: I. Pakkala et al., MC1288, A VITAMIN-D ANALOG, IN THE PREVENTION OF AGVHD IN THE RAT, Blood, 90(10), 1997, pp. 4189-4189
Authors:
PAKKALA S
SPROGEL P
REMES K
NOUSIAINEN T
KOIVUNEN E
PELLINIEMI TT
RUUTU T
ELONEN E
Citation: S. Pakkala et al., EB1089, A VITAMIN-D ANALOG IN MDS AND AML, Blood, 90(10), 1997, pp. 2265-2265
Authors:
KUUSANMAKI P
PAAVONEN T
PAKKALA S
LAURONEN J
PAKARINEN M
HAYRY P
HALTTUNEN J
Citation: P. Kuusanmaki et al., BRUSH CYTOLOGY IN THE COURSE OF ACUTE SMALL-BOWEL ALLOGRAFT-REJECTION, Acta cytologica, 41(5), 1997, pp. 1500-1509
Authors:
TIKKANEN I
SALMELA K
HOHENTHAL U
TEPPO AM
PAKKALA S
AHONEN J
FYHRQUIST F
Citation: I. Tikkanen et al., INCREASED SERUM NEUTRAL ENDOPEPTIDASE ACTIVITY IN ACUTE RENAL-ALLOGRAFT REJECTION, American journal of nephrology, 16(4), 1996, pp. 273-279
Authors:
SAND J
PAKKALA S
NORDBACK I
Citation: J. Sand et al., 20 TO 30 YEAR FOLLOW-UP AFTER CHOLECYSTECTOMY, Hepato-gastroenterology, 43(9), 1996, pp. 534-537
Authors:
KALLIO E
HAYRY P
PAKKALA S
Citation: E. Kallio et al., MC1288, A VITAMIN-D ANALOG, REDUCES SHORT-TERM AND LONG-TERM RENAL-ALLOGRAFT REJECTION IN THE RAT, Transplantation proceedings, 28(6), 1996, pp. 3113-3113
Authors:
RAISANENSOKOLOWSKI A
PAKKALA I
VUORISTO P
SAMILA S
BINDERUP L
HAYRY P
PAKKALA S
Citation: A. Raisanensokolowski et al., EFFECT OF MC1288, A VITAMIN-D ANALOG, ON LYMPHOCYTE-PROLIFERATION IN-VITRO AND RAT AORTIC ALLOGRAFT ARTERIOSCLEROSIS IN-VIVO, Transplantation proceedings, 28(2), 1996, pp. 919-919
Authors:
HUOTARI MA
USTINOV J
AAVIK E
PAKKALA S
OTONKOSKI T
Citation: Ma. Huotari et al., GROWTH AND DIFFERENTIATION FACTORS IN PANCREATIC BETA-CELLS - INS-1 RAT INSULINOMA CELL-LINE AS A MODEL, Diabetologia, 39, 1996, pp. 233-233
Authors:
KIZAKI M
DAWSON MI
HEYMAN R
ELSTNER E
MOROSETTI R
PAKKALA S
CHEN DL
UENO H
CHAO WR
MORIKAWA M
IKEDA Y
HEBER D
PFAHL M
KOEFFLER HP
Citation: M. Kizaki et al., EFFECTS OF NOVEL RETINOID X RECEPTOR-SELECTIVE LIGANDS ON MYELOID LEUKEMIC DIFFERENTIATION AND PROLIFERATION IN-VITRO, Blood, 87(5), 1996, pp. 1977-1984
Authors:
PAKKALA S
DEVOS S
ELSTNER E
RUDE RK
USKOKOVIC M
BINDERUP L
KOEFFLER HP
Citation: S. Pakkala et al., VITAMIN-D-3 ANALOGS - EFFECT ON LEUKEMIC CLONAL GROWTH AND DIFFERENTIATION, AND ON SERUM-CALCIUM LEVELS, Leukemia research, 19(1), 1995, pp. 65-72
Authors:
NAKAWAKI T
KAWAMATA N
SCHWALLER J
TOBLER A
FEY M
PAKKALA S
LEE YY
KIM BK
FUKUCHI K
TSURUOKA N
KAHAN J
Citation: T. Nakawaki et al., STRUCTURAL INTEGRITY OF THE CYCLIN-DEPENDENT KINASE INHIBITOR GENES, P15, P16 AND P18 IN MYELOID LEUKEMIAS, British Journal of Haematology, 91(1), 1995, pp. 139-149
Authors:
PAKKALA I
SAVLI H
BINDERUP L
PAKKALA S
Citation: I. Pakkala et al., THE EFFECTS OF CB-1093, A NOVEL VITAMIN-D-3 ANALOG ON CLONAL GROWTH AND DIFFERENTIATION OF HL-60 CELLS AND DE-NOVO LEUKEMIA-CELLS, Blood, 86(10), 1995, pp. 3087-3087
Authors:
MUHONEN T
HAHKAKEMPPINEN M
PAKKALA S
PYRHONEN S
Citation: T. Muhonen et al., DECREASING CD4 CD8 RATIO DURING PROLONGED 4-DRUG CHEMOTHERAPY PLUS INTERFERON TREATMENT FOR METASTATIC MELANOMA/, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 67-73
Authors:
PAKKALA S
LUKKA M
HELMINEN P
KOSKIMIES S
RUUTU T
Citation: S. Pakkala et al., PATERNITY AFTER BONE-MARROW TRANSPLANTATION FOLLOWING CONDITIONING WITH TOTAL-BODY IRRADIATION, Bone marrow transplantation, 13(4), 1994, pp. 489-490
Authors:
JUNG SJ
LEE YY
PAKKALA S
DEVOS S
ELSTNER E
NORMAN AW
GREEN J
USKOKOVIC M
KOEFFLER HP
Citation: Sj. Jung et al., 1,25(OH)(2)-16-ENE-VITAMIN-D-3 IS A POTENT ANTILEUKEMIC AGENT WITH LOW POTENTIAL TO CAUSE HYPERCALCEMIA, Leukemia research, 18(6), 1994, pp. 453-463
Authors:
HEIKINHEIMO M
PAKKALA S
JUVONEN E
SAARINEN UM
Citation: M. Heikinheimo et al., IMMUNOCHEMICAL AND CYTOCHEMICAL CHARACTERIZATION OF CONGENITAL LEUKEMIA - A CASE-REPORT, Medical and pediatric oncology, 22(4), 1994, pp. 279-282
Authors:
ELSTNER E
LEE YY
HASHIYA M
PAKKALA S
BINDERUP L
NORMAN AW
OKAMURA WH
KOEFFLER HP
Citation: E. Elstner et al., 1-ALPHA,25-DIHYDROXY-20-EPI-VITAMIN-D-3 - AN EXTRAORDINARILY POTENT INHIBITOR OF LEUKEMIC-CELL GROWTH IN-VITRO, Blood, 84(6), 1994, pp. 1960-1967
Authors:
DAWSON MI
ELSTNER E
KIZAKI M
CHEN DL
PAKKALA S
KERNER B
KOEFFLER HP
Citation: Mi. Dawson et al., MYELOID DIFFERENTIATION MEDIATED THROUGH RETINOIC ACID RECEPTOR RETINOIC-X RECEPTOR (RXR) NOT RXR RXR PATHWAY/, Blood, 84(2), 1994, pp. 446-452
Authors:
SALO A
PAKKALA S
JANSSON SE
HELMINEN P
PALOTIE A
Citation: A. Salo et al., MONITORING OF ADULT B-CELL LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - VALIDATION OF A SIMPLE METHOD FOR DETECTING IMMUNOGLOBULIN HEAVY-CHAIN GENE CLONALITY, Leukemia, 7(9), 1993, pp. 1459-1465
Authors:
ELSTNER E
LEE YY
HACHIYA M
PAKKALA S
NORMAN A
BINDERUP L
KOEFFLER HP
Citation: E. Elstner et al., 20-EPI-VITAMIN-D3 ANALOG - AN EXTRAORDINARILY POTENT INHIBITOR OF LEUKEMIC-CELL GROWTH IN-VITRO, Blood, 82(10), 1993, pp. 10000254-10000254
Authors:
PAKKALA S
DEVOS S
ELSTNER E
RUDE B
USKOKOVIC M
BINDERUP L
KOEFFLER HP
Citation: S. Pakkala et al., ANTILEUKEMIC ACTIVITIES AND EFFECTS ON SERUM-CALCIUM OF 3 NOVEL VITAMIN-D3 ANALOGS, Blood, 82(10), 1993, pp. 10000255-10000255
Risultati:
1-23
|